CDC data indicates "breakthrough" coronavirus infections have struck just 0.098% of vaccinated Americans—and most vaccinated people who do get infected have no or mild symptoms. But what's it actually like to have a rare breakthrough infection? Here is how several patients describe their own experiences.
The U.K. has recently reversed a surge in Covid-19 cases caused by the delta variant—and while experts don't fully understand why the British surge has faded, they point to three potential explanations that may have implications for the United States, David Wallace-Wells reports for New York Magazine's "Intelligencer."
Insurers often steer patients to urgent care clinics to avoid unnecessary ED utilization. But, as one man's experience with a $1,040 surprise bill shows, the regulatory "gray area" of urgent care clinics could expose patients to significant financial risks, Rachana Pradhan writes for Kaiser Health News/NBC News.
Nearly half of the 253 drugs authorized via FDA's accelerated approval pathway since 1992 have never been confirmed as clinically effective—leading some experts to suggest the approval process has been "exploited, to the detriment of patients … and of taxpayers," Elizabeth Mahase writes for The BMJ.
FDA last week approved a biosimilar insulin drug for interchangeable use for those with diabetes, in today's bite-sized hospital and health industry news from California, the District of Columbia, and Texas.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.